BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12481939)

  • 1. Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study.
    Schönberger J; Rüschoff J; Grimm D; Marienhagen J; Rümmele P; Meyringer R; Kossmehl P; Hofstaedter F; Eilles C
    Thyroid; 2002 Sep; 12(9):747-54. PubMed ID: 12481939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
    Brown RS; Wahl RL
    Cancer; 1993 Nov; 72(10):2979-85. PubMed ID: 8221565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
    Grabellus F; Nagarajah J; Bockisch A; Schmid KW; Sheu SY
    Clin Nucl Med; 2012 Feb; 37(2):121-7. PubMed ID: 22228332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
    Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
    Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
    Ciampi R; Vivaldi A; Romei C; Del Guerra A; Salvadori P; Cosci B; Pinchera A; Elisei R
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):57-62. PubMed ID: 18571834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
    Haber RS; Weiser KR; Pritsker A; Reder I; Burstein DE
    Thyroid; 1997 Jun; 7(3):363-7. PubMed ID: 9226204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of facilitative glucose transporter isoforms in human brain tumors.
    Nagamatsu S; Sawa H; Wakizaka A; Hoshino T
    J Neurochem; 1993 Dec; 61(6):2048-53. PubMed ID: 8245960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
    Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of glucose transporters in normal and pathologic thyroid tissue.
    Matsuzu K; Segade F; Matsuzu U; Carter A; Bowden DW; Perrier ND
    Thyroid; 2004 Oct; 14(10):806-12. PubMed ID: 15588375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
    Musholt TJ; Musholt PB; Dehdashti F; Moley JF
    Surgery; 1997 Dec; 122(6):1049-60; discussion 1060-1. PubMed ID: 9426419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival.
    Younes M; Brown RW; Stephenson M; Gondo M; Cagle PT
    Cancer; 1997 Sep; 80(6):1046-51. PubMed ID: 9305704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
    Park SG; Lee JH; Lee WA; Han KM
    Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
    Younes M; Juarez D; Lechago LV; Lerner SP
    Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
    Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.
    Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M
    Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of facilitated-diffusion glucose transporters in rat pancreatic islets.
    Sato Y; Ito T; Udaka N; Kanisawa M; Noguchi Y; Cushman SW; Satoh S
    Tissue Cell; 1996 Dec; 28(6):637-43. PubMed ID: 9004533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.
    Rudlowski C; Moser M; Becker AJ; Rath W; Buttner R; Schroder W; Schurmann A
    Oncology; 2004; 66(5):404-10. PubMed ID: 15331928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
    Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K
    Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolysis-related protein expression in thyroid cancer.
    Nahm JH; Kim HM; Koo JS
    Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.